Knee Osteoarthritis (Kellgren-Lawrence Grade 1-3)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Knee Osteoarthritis (Kellgren-Lawrence Grade 1-3) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (4 shown)

Active — Not RecruitingNot Applicable

NCT07410429

Targeted Rehabilitation Versus Standard Care in Managing Medial Knee Pain and Varus Malalignment: A Randomized Control T…

Medial knee pain with varus alignment is common in active adults and is associated with increased medial joint loading, cartilage loss, and progression of knee…

Egypt80 participantsStarted 2025-10-01

Treatment: Conventional Knee Physical Therapy Program, Targeted Alignment-Focused Exercise Program for Varus Knee

Active — Not RecruitingPhase 1/2

NCT04875754

A Study Evaluating the Safety, Tolerability, and Range of Biologically Active Doses of ICM-203 in Mild to Moderate Knee…

The purpose of this study is to determine the safety, tolerability, and activity of ICM-203, a recombinant adeno-associated viral (AAV) vector that expresses a…

Australia16 participantsStarted 2022-03-17

Treatment: ICM-203, Placebo

Active — Not RecruitingNot Applicable

NCT06416332

Development and Testing of a Tele-rehabilitation System for Adult Patients With Knee Osteoarthritis

DEVELOPMENT AND TESTING OF A TELEREHABILITION SYSTEM FOR PATIENTS WITH OSTEOARTHRITIS OF THE. KNEE (AGES 40-70 YEARS, GRADE 1-3, ACCORDING TO KELLGREN AND LAWRE…

Greece34 participantsStarted 2022-09-13

Treatment: group A: in face to face live therapeutic exercise, group B: telerehabilitation program

CompletedPhase 3

NCT01967550

Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)

This study will evaluate the efficacy and safety of diclofenac DDEA 2.32 % in patient suffering from knee osteoarthritis (OA).

Germany304 participantsStarted 2013-10

Treatment: diclofenac diethylamine, DDEA 2.32% gel, Placebo